PBAC Budesonide (Jorveza®) submission for use in EoE (Eosinophilic Oesoghagitis) - 22 Sep 2021
Allergy & Anaphylaxis Australia lodged comments in support of the application for Pharmaceutical Benefits Scheme (PBS) listing of JORVEZA® for both induction of remission and maintenance of remission in adult patients with Eosinophilic Oesophagitis (EoE).